Biofrontera (BFRIW) Amortizatization of Intangibles (2020 - 2025)
Biofrontera (BFRIW) recorded quarterly Amortizatization of Intangibles of $158000.0 in Q4 2025, down 71.99% quarter-over-quarter from $564000.0 in Q3 2025, and down 15.51% on a YoY basis from $187000.0 in Q4 2024.
Biofrontera (BFRIW) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Biofrontera's Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $158000.0 for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles fell 15.51% year-over-year to $158000.0; the TTM figure through Dec 2025 stood at $730000.0 (down 7.71% YoY), while the FY2025 annual figure was $730000.0, changed 0.27% from the prior year.
- Amortizatization of Intangibles was $158000.0 for Q4 2025 at Biofrontera, down from $564000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $564000.0 in Q3 2025 to a low of -$182000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $157500.0 across 5 years, with a median of $102500.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles surged 310.47% in 2022, then slumped 282.0% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $86000.0 in 2021, then soared by 310.47% to $353000.0 in 2022, then sank by 30.31% to $246000.0 in 2023, then decreased by 23.98% to $187000.0 in 2024, then dropped by 15.51% to $158000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $158000.0 (Q4 2025), $564000.0 (Q3 2025), and -$182000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Biofrontera | - | - | 14.09 Mn | 158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 158,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 564,000.00 |
| Sep 30, 2025 | 564,000.00 |
| Jun 30, 2025 | -182,000.00 |
| Jun 30, 2025 | -182,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 187,000.00 |
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 325,000.00 |
| Sep 30, 2024 | 325,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 179,000.00 |
| Mar 31, 2024 | 179,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |